人工括約肌對於攝護腺手術後尿失禁的治療: 四個醫療機構二十二年的經驗統整

周敬哲、林政鋒、劉冠麟、陳文祥、林承家、陳鴻毅、吳翊豪、楊昀達

基隆長庚紀念醫院 外科部 泌尿科

Artificial urinary sphincters in the treatment of post-prostatectomy incontinence: A summary of 22 years of experience from 4 medical institutions

Ching-Che Chou, Cheng-Feng Lin, Kuan-Lin Liu, Wen-Hsiang Chen, Cheng-Chia Lin, Hung Yi Chen, Yi-Hao Wu, Yun-Ta Yang

Divisions of Urology, Department of Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan

 

PurposeA review of artificial urinary sphincter implantations with AMS-800 in patients with post-prostatectomy incontinence over a course of 22 years.

Materials and methods:  Between 1999 and 2021, 39 patients who had undergone a total of 45 artificial urinary sphincter implantations were retrospectively analyzed.  The patients included met the inclusion criteria for post-prostatectomy incontinence and those with previous rectal surgeries, previous spinal surgeries and those with incontinence period less than 1 year were excluded.   Data was collected over 4 medical institutions in Taiwan with a mean follow up time of 32.8 months.

ResultsThe artificial urinary sphincter reached a cure rate (0 pads) of 77.77% and a socially continent rate of 84.44%.  The implantation took a median operation time of 137 minutes, median blood loss 0 – 5 cc and a median of 6 days of hospital admission. Overall complication rate was 40% where 44.44% were due to infections, 38.89% due to mechanical failures, 27.78% due to erosions and 11.11% due to acute urinary retention.  All – cause device failure rate was 37.78% with median device survival time of 81 months.  Survival rate was 72.5% at 1 year, 69.2% at 3 years and 65.3% at 5 years.  Patients with history of transurethral procedures were associated with higher risk of device failure.

Conclusions:  The artificial urinary sphincter is a safe and efficient way of treating patients with post-prostatectomy incontinence.  Patients however need to be informed about the possible complications associated with device implantation, associated risk factors as well as device survival time.

    位置
    資料夾名稱
    摘要
    發表人
    陳佳能
    單位
    台灣泌尿科醫學會
    建立
    2023-07-05 16:23:58
    最近修訂
    2023-07-05 16:24:26
    更多